{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:50:40Z","timestamp":1788922240910,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130056"],"award-info":[{"award-number":["82130056"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Science and Technology Project of Zhejiang Provience","award":["2022KY342"],"award-info":[{"award-number":["2022KY342"]}]},{"name":"Research Program on the Guiding Principles for the Formulation and Adjustment of the Control Level for Narcotic and Psychotropic Substances","award":["RS2024H006"],"award-info":[{"award-number":["RS2024H006"]}]},{"name":"Ningbo Public Welfare Research Project","award":["2024S025"],"award-info":[{"award-number":["2024S025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00213-025-06790-2","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:07:42Z","timestamp":1744848462000},"page":"2123-2133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Assessment of abuse potential of furanylfentanyl and tetrahydrofuranylfentanyl"],"prefix":"10.1007","volume":"242","author":[{"given":"Yuanyuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaojun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"6790_CR1","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s00213-016-4296-8","volume":"233","author":"JP Anand","year":"2016","unstructured":"Anand JP, Boyer BT, Mosberg HI et al (2016) The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice. Psychopharmacology 233:2479\u20132487. https:\/\/doi.org\/10.1007\/s00213-016-4296-8","journal-title":"Psychopharmacology"},{"key":"6790_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2906","author":"A \u00c5strand","year":"2020","unstructured":"\u00c5strand A, Vikingsson S, Jakobsen I et al (2020) Activation of the \u00b5-opioid receptor by alicyclic fentanyls: changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure. Drug Test Anal. https:\/\/doi.org\/10.1002\/dta.2906","journal-title":"Drug Test Anal"},{"key":"6790_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/dta.2472","volume":"11","author":"LM Barbosa","year":"2019","unstructured":"Barbosa LM, Santos JM, de Morais DR et al (2019) Fast UHPLC-MS\/MS method for analysis of furanylfentanyl in different seized blotter papers. Drug Test Anal 11:178\u2013183. https:\/\/doi.org\/10.1002\/dta.2472","journal-title":"Drug Test Anal"},{"key":"6790_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.biopsych.2015.01.004","volume":"79","author":"A Belin-Rauscent","year":"2016","unstructured":"Belin-Rauscent A, Fouyssac M, Bonci A et al (2016) How preclinical models evolved to resemble the diagnostic criteria of drug addiction. Biol Psychiatry 79:39\u201346. https:\/\/doi.org\/10.1016\/j.biopsych.2015.01.004","journal-title":"Biol Psychiatry"},{"key":"6790_CR5","doi-asserted-by":"publisher","first-page":"109020","DOI":"10.1016\/j.neuropharm.2022.109020","volume":"209","author":"S Bilel","year":"2022","unstructured":"Bilel S, Azevedo Neto J, Arf\u00e8 R et al (2022) In vitro and in vivo pharmaco-dynamic study of the novel Fentanyl derivatives: Acrylfentanyl, Ocfentanyl and furanylfentanyl. Neuropharmacology 209:109020. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109020","journal-title":"Neuropharmacology"},{"key":"6790_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00204-024-03887-z","volume":"99","author":"JR Canfield","year":"2025","unstructured":"Canfield JR, Sprague JE (2025) In vivo Pharmacokinetic, pharmacodynamic and brain concentration comparison of Fentanyl and para-fluorofentanyl in rats. Arch Toxicol 99:287\u2013297. https:\/\/doi.org\/10.1007\/s00204-024-03887-z","journal-title":"Arch Toxicol"},{"key":"6790_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-024-07440-x","volume":"630","author":"F Chaudun","year":"2024","unstructured":"Chaudun F, Python L, Liu Y et al (2024) Distinct \u00b5-opioid ensembles trigger positive and negative Fentanyl reinforcement. Nature 630:141\u2013148. https:\/\/doi.org\/10.1038\/s41586-024-07440-x","journal-title":"Nature"},{"key":"6790_CR8","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/nprot.2006.279","volume":"1","author":"CL Cunningham","year":"2006","unstructured":"Cunningham CL, Gremel CM, Groblewski PA (2006) Drug-induced conditioned place preference and aversion in mice. Nat Protoc 1:1662\u20131670. https:\/\/doi.org\/10.1038\/nprot.2006.279","journal-title":"Nat Protoc"},{"key":"6790_CR9","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1016\/j.bmc.2005.12.010","volume":"14","author":"L Dosen-Micovic","year":"2006","unstructured":"Dosen-Micovic L, Ivanovic M, Micovic V (2006) Steric interactions and the activity of Fentanyl analogs at the mu-opioid receptor. Bioorg Med Chem 14:2887\u20132895. https:\/\/doi.org\/10.1016\/j.bmc.2005.12.010","journal-title":"Bioorg Med Chem"},{"key":"6790_CR10","unstructured":"EMCDDA (2017) Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl) in the framework of the Council decision on new psychoactive substances. https:\/\/www.emcdda.europa.eu\/publications\/joint-reports\/furanylfentanyl"},{"key":"6790_CR11","unstructured":"EMCDDA (2018) Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]oxolane-2-carboxamide (THF-F) in the framework of the Council decision on new psychoactive substances 2018.https:\/\/www.emcdda.europa.eu\/publications\/risk-assessments\/thf-f_en"},{"key":"6790_CR12","doi-asserted-by":"publisher","first-page":"114293","DOI":"10.1016\/j.bcp.2020.114293","volume":"182","author":"AJ Eshleman","year":"2020","unstructured":"Eshleman AJ, Nagarajan S, Wolfrum KM et al (2020) Affinity, potency, efficacy, selectivity, and molecular modeling of substituted Fentanyls at opioid receptors. Biochem Pharmacol 182:114293. https:\/\/doi.org\/10.1016\/j.bcp.2020.114293","journal-title":"Biochem Pharmacol"},{"key":"6790_CR13","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.tips.2020.09.009","volume":"41","author":"A Gillis","year":"2020","unstructured":"Gillis A, Kliewer A, Kelly E et al (2020) Critical assessment of G Protein-Biased agonism at the \u00b5-Opioid receptor. Trends Pharmacol Sci 41:947\u2013959. https:\/\/doi.org\/10.1016\/j.tips.2020.09.009","journal-title":"Trends Pharmacol Sci"},{"key":"6790_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.tips.2013.01.004","volume":"34","author":"JP Huston","year":"2013","unstructured":"Huston JP, Silva MA, Topic B et al (2013) What\u2019s conditioned in conditioned place preference? Trends Pharmacol Sci 34:162\u2013166. https:\/\/doi.org\/10.1016\/j.tips.2013.01.004","journal-title":"Trends Pharmacol Sci"},{"key":"6790_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fnbeh.2020.00074","volume":"14","author":"SS Kokane","year":"2020","unstructured":"Kokane SS, Perrotti LI (2020) Sex differences and the role of estradiol in mesolimbic reward circuits and vulnerability to cocaine and opiate addiction. Front Behav Neurosci 14:74. https:\/\/doi.org\/10.3389\/fnbeh.2020.00074","journal-title":"Front Behav Neurosci"},{"key":"6790_CR16","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1093\/jat\/bkx092","volume":"42","author":"AJ Krotulski","year":"2018","unstructured":"Krotulski AJ, Papsun DM, Friscia M et al (2018) Fatality following ingestion of tetrahydrofuranylfentanyl, U-49900 and Methoxy-Phencyclidine. J Anal Toxicol 42:e27\u2013e32. https:\/\/doi.org\/10.1093\/jat\/bkx092","journal-title":"J Anal Toxicol"},{"key":"6790_CR17","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1007\/s00213-022-06173-x","volume":"239","author":"M Lai","year":"2022","unstructured":"Lai M, Fu D, Xu Z et al (2022) Relative reinforcing effects of dibutylone, Ethylone, and N-ethylpentylone: self-administration and behavioral economics analysis in rats. Psychopharmacology 239:2875\u20132884. https:\/\/doi.org\/10.1007\/s00213-022-06173-x","journal-title":"Psychopharmacology"},{"key":"6790_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.15900\/j.cnki.zylf1995.2020.04.003","volume":"26","author":"X Li","year":"2020","unstructured":"Li X, Chen Y, Li F et al (2020) Comparative research on analgesic effects of Fentanyl and Furanyfentanyl. Chin J Drug Abuse Prev Treat 26:198\u2013202. https:\/\/doi.org\/10.15900\/j.cnki.zylf1995.2020.04.003","journal-title":"Chin J Drug Abuse Prev Treat"},{"key":"6790_CR18","doi-asserted-by":"publisher","first-page":"e13171","DOI":"10.1111\/adb.13171","volume":"17","author":"F Li","year":"2022","unstructured":"Li F, Du H, Wu B et al (2022) 2-Fluorodeschloroketamine has similar abuse potential as ketamine. Addict Biol 17:e13171. https:\/\/doi.org\/10.1111\/adb.13171","journal-title":"Addict Biol"},{"key":"6790_CR20","doi-asserted-by":"publisher","unstructured":"Maitland AD, McGriff SA, Glatfelter GC et al (2024) Reinforcing effects of fentanyl analogs found in illicit drug markets. Psychopharmacology (Berl). https:\/\/doi.org\/10.1007\/s00213-024-06641-6","DOI":"10.1007\/s00213-024-06641-6"},{"key":"6790_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ejphar.2013.05.015","volume":"715","author":"T Mori","year":"2013","unstructured":"Mori T, Komiya S, Uzawa N et al (2013) Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of \u00b5-opioid receptor agonist-induced physical dependence. Eur J Pharmacol 715:238\u2013245. https:\/\/doi.org\/10.1016\/j.ejphar.2013.05.015","journal-title":"Eur J Pharmacol"},{"key":"6790_CR22","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.tips.2018.08.007","volume":"39","author":"SS Negus","year":"2018","unstructured":"Negus SS, Freeman KB (2018) Abuse potential of biased mu opioid receptor agonists. Trends Pharmacol Sci 39:916\u2013919. https:\/\/doi.org\/10.1016\/j.tips.2018.08.007","journal-title":"Trends Pharmacol Sci"},{"key":"6790_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.15585\/mmwr.mm6910a4","volume":"69","author":"J O\u2019Donnell","year":"2020","unstructured":"O\u2019Donnell J, Gladden RM, Goldberger BA et al (2020) Notes from the field: Opioid-Involved overdose deaths with Fentanyl or Fentanyl analogs detected\u2013\u200928 States and the district of Columbia, July 2016-December 2018. MMWR Morb Mortal Wkly Rep 69:271\u2013273. https:\/\/doi.org\/10.15585\/mmwr.mm6910a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6790_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neuropharm.2010.08.003","volume":"60","author":"KM Raehal","year":"2011","unstructured":"Raehal KM, Bohn LM (2011) The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics. Neuropharmacology 60:58\u201365. https:\/\/doi.org\/10.1016\/j.neuropharm.2010.08.003","journal-title":"Neuropharmacology"},{"key":"6790_CR25","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/adb.12382","volume":"21","author":"C Sanchis-Segura","year":"2016","unstructured":"Sanchis-Segura C, Becker JB (2016) Why we should consider sex (and study sex differences) in addiction research. Addict Biol 21:995\u20131006. https:\/\/doi.org\/10.1111\/adb.12382","journal-title":"Addict Biol"},{"key":"6790_CR26","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","volume":"171","author":"CL Schmid","year":"2017","unstructured":"Schmid CL, Kennedy NM, Ross NC et al (2017) Bias factor and therapeutic window correlate to predict safer opioid analgesics. Cell 171:1165\u20131175e13. https:\/\/doi.org\/10.1016\/j.cell.2017.10.035","journal-title":"Cell"},{"key":"6790_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pbb.2015.02.022","volume":"132","author":"GW Stevenson","year":"2015","unstructured":"Stevenson GW, Luginbuhl A, Dunbar C et al (2015) The mixed-action delta\/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence. Pharmacol Biochem Behav 132:49\u201355. https:\/\/doi.org\/10.1016\/j.pbb.2015.02.022","journal-title":"Pharmacol Biochem Behav"},{"key":"6790_CR28","doi-asserted-by":"publisher","first-page":"e12845","DOI":"10.1111\/adb.12845","volume":"25","author":"M Sustkova-Fiserova","year":"2020","unstructured":"Sustkova-Fiserova M, Puskina N, Havlickova T et al (2020) Ghrelin receptor antagonism of fentanyl-induced conditioned place preference, intravenous self-administration, and dopamine release in the nucleus accumbens in rats. Addict Biol 25:e12845. https:\/\/doi.org\/10.1111\/adb.12845","journal-title":"Addict Biol"},{"key":"6790_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.15585\/mmwr.mm7306a2","volume":"73","author":"LJ Tanz","year":"2024","unstructured":"Tanz LJ, Gladden RM, Dinwiddie AT et al (2024) Routes of drug use among drug overdose Deaths - United States, 2020\u20132022. MMWR Morb Mortal Wkly Rep 73:124\u2013130. https:\/\/doi.org\/10.15585\/mmwr.mm7306a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6790_CR30","doi-asserted-by":"publisher","first-page":"e2435895","DOI":"10.1001\/jamanetworkopen.2024.35895","volume":"7","author":"AP Thakrar","year":"2024","unstructured":"Thakrar AP, Christine PJ, Siaw-Asamoah A et al (2024) Buprenorphine-Precipitated withdrawal among hospitalized patients using Fentanyl. JAMA Netw Open 7:e2435895. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.35895","journal-title":"JAMA Netw Open"},{"key":"6790_CR31","doi-asserted-by":"publisher","first-page":"841873","DOI":"10.3389\/fphar.2022.841873","volume":"13","author":"EB Towers","year":"2022","unstructured":"Towers EB, Setaro B, Lynch WJ (2022) Sex- and Dose-Dependent differences in the development of an Addiction-Like phenotype following Extended-Access Fentanyl Self-Administration. Front Pharmacol 13:841873. https:\/\/doi.org\/10.3389\/fphar.2022.841873","journal-title":"Front Pharmacol"},{"key":"6790_CR32","unstructured":"UNODC (2019) World Drug Report.https:\/\/www.unodc.org\/unodc\/en\/frontpage\/2019\/June\/world-drug-report-2019_-35-million-people-worldwide-suffer-from-drug-use-disorders-while-only-1-in-7-people-receive-treatment.html?ref=fs1"},{"key":"6790_CR33","unstructured":"UNODC (2023) UNODC Early Warning Advisory on New Psychoactive Substances.https:\/\/www.unodc.org\/LSS\/Home\/NPS"},{"key":"6790_CR34","unstructured":"UNODC (2024) World Drug Report.https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2024.html"},{"key":"6790_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4155\/fmc.13.215","volume":"6","author":"RS Vardanyan","year":"2014","unstructured":"Vardanyan RS, Hruby VJ (2014) Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications. Future Med Chem 6:385\u2013412. https:\/\/doi.org\/10.4155\/fmc.13.215","journal-title":"Future Med Chem"},{"key":"6790_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.neuropharm.2019.03.023","volume":"151","author":"NB Varshneya","year":"2019","unstructured":"Varshneya NB, Walentiny DM, Moisa LT et al (2019) Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances. Neuropharmacology 151:171\u2013179. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.03.023","journal-title":"Neuropharmacology"},{"key":"6790_CR37","doi-asserted-by":"publisher","first-page":"113910","DOI":"10.1016\/j.bcp.2020.113910","volume":"177","author":"L Vasudevan","year":"2020","unstructured":"Vasudevan L, Vandeputte M, Deventer M et al (2020) Assessment of structure-activity relationships and biased agonism at the mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform. Biochem Pharmacol 177:113910. https:\/\/doi.org\/10.1016\/j.bcp.2020.113910","journal-title":"Biochem Pharmacol"},{"key":"6790_CR38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","volume":"76","author":"ND Volkow","year":"2019","unstructured":"Volkow ND, Jones EB, Einstein EB et al (2019) Prevention and treatment of opioid misuse and addiction: A review. JAMA Psychiatry 76:208\u2013216. https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.3126","journal-title":"JAMA Psychiatry"},{"key":"6790_CR39","doi-asserted-by":"publisher","first-page":"e13265","DOI":"10.1111\/adb.13265","volume":"28","author":"J Wei","year":"2023","unstructured":"Wei J, Lai M, Li F et al (2023) Assessment of abuse potential of carfentanil. Addict Biol 28:e13265. https:\/\/doi.org\/10.1111\/adb.13265","journal-title":"Addict Biol"},{"key":"6790_CR40","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fphar.2019.00238","volume":"10","author":"M Wilde","year":"2019","unstructured":"Wilde M, Pichini S, Pacifici R et al (2019) Metabolic pathways and potencies of new Fentanyl analogs. Front Pharmacol 10:238. https:\/\/doi.org\/10.3389\/fphar.2019.00238","journal-title":"Front Pharmacol"},{"key":"6790_CR42","doi-asserted-by":"publisher","first-page":"173128","DOI":"10.1016\/j.pbb.2021.173128","volume":"203","author":"P Xu","year":"2021","unstructured":"Xu P, Lai M, Fu D et al (2021) Reinforcing and discriminative-stimulus effects of two pyrrolidine-containing synthetic Cathinone derivatives in rats. Pharmacol Biochem Behav 203:173128. https:\/\/doi.org\/10.1016\/j.pbb.2021.173128","journal-title":"Pharmacol Biochem Behav"},{"key":"6790_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-024-06664-z","author":"D Xu","year":"2024","unstructured":"Xu D, Kuai L, Chen Y et al (2024) Isobutyryl-carfentanyl has strong acute toxicity and analgesic effects with high addiction potential. Psychopharmacology. https:\/\/doi.org\/10.1007\/s00213-024-06664-z","journal-title":"Psychopharmacology"},{"key":"6790_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neulet.2012.05.037","volume":"520","author":"M Zhang","year":"2012","unstructured":"Zhang M, Jing L, Liu Q et al (2012) Tramadol induces conditioned place preference in rats: interactions with morphine and buprenorphine. Neurosci Lett 520:87\u201391. https:\/\/doi.org\/10.1016\/j.neulet.2012.05.037","journal-title":"Neurosci Lett"},{"key":"6790_CR44","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1016\/j.cell.2022.09.041","volume":"185","author":"Y Zhuang","year":"2022","unstructured":"Zhuang Y, Wang Y, He B et al (2022) Molecular recognition of morphine and Fentanyl by the human \u00b5-opioid receptor. Cell 185:4361\u20134375e19. https:\/\/doi.org\/10.1016\/j.cell.2022.09.041","journal-title":"Cell"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-025-06790-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T19:03:07Z","timestamp":1756234987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-025-06790-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["6790"],"URL":"https:\/\/doi.org\/10.1007\/s00213-025-06790-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflict of interest related to this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}